Barbara Milczarek for The World of Pharmaceutical Industry Magazine!
In order to patent a new chemical compound, which is to be used for medical purposes, it is necessary to present already in the patent application the results of a research confirming its therapeutic effects.
In the latest issue of the magazine “The World of Pharmaceutical Industry” (“Świat Przemysłu Farmaceutycznego”) Barbara Milczarek, a patent attorney at Patpol, discussed the obligation of a sufficient disclosure of invention in the context of the application procedures.
We invite you to read the full article in polish.
In my previous entry to IP Blog ? "The devil is in the details..., or Czytaj dalej
We are delighted to inform that Aleksandra Kryska our Deputy Head of Trade Mark and Czytaj dalej
How to protect trademarks properly and what to do when the competition infringements our protection Czytaj dalej
